exhibit 10. 6 compound assignment agreement in consideration of the mutual promises set forth in this compound assignment agreement ( the " agreement " ), geetha kamburath,, residing at skanda kripa, payalore, kerala, india ) ( the " inventor " ) and cellceutix corporation, a delaware corporation with an office at 760 main st., willmington ma 01887 ( " cellceutix " ) agree as follows : 2. the assignment of the rights to the compound includes but is not limited to : a ) all data relating to the compound developed by the inventor prior to the agreement or hereafter ; b ) any patents, patent applications, trademarks and copyrights covering the compound. 3. the inventor agrees to provide reasonable assistance to cellceutix in filing and prosecuting patent applications related to the compound as well as in enforcing patents and other intellectual property relating to the compound. cellceutix will reimburse the inventor for any expenses reasonably incurred in providing this assistance. 4. cellceutix will use reasonable efforts to develop the compound giving consideration to the funding available to cellceutix. if cellceutix decides in the reasonable exercise of its business judgment to develop another substance in preference to the compound, that will not be considered a breach of this agreement. 5. cellceutix will pay all expenses associated with developing the compound. 6. cellceutix will pay the inventor 5 % of the net sales of the compound for as long as there is a composition of matter patent in force in the country in which the sale takes place. if no composition of matter patent is issued in a particular country, cellceutix will pay the inventor 3 % of net sales in that country for a period of 10 years from the first commercial sale.